Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1984 Apr;47(4):338–343. doi: 10.1136/jnnp.47.4.338

Low platelet monoamine oxidase activity in headache: no correlation with phenolsulphotransferase, succinate dehydrogenase, platelet preparation method or smoking.

J Littlewood, V Glover, M Sandler, R Peatfield, R Petty, F Clifford Rose
PMCID: PMC1027773  PMID: 6587008

Abstract

Platelet monoamine oxidase activity in male migrainous and cluster headache patients was significantly lower than in male controls, confirming our previous study. The activity range showed a normal distribution and low mean values could not be attributed to a subgroup with particularly low activity. When Corash 's platelet preparation method was used, with its high platelet yield, specific enzyme activities of a similar order were obtained. Thus, the low values encountered were not due to abnormal recovery within the platelet population. Two other enzyme activities, phenolsulphotransferase M and succinate dehydrogenase, were also measured in the same platelet samples. Although low succinate dehydrogenase activity was identified in the headache groups, it appeared to represent a separate phenomenon and there was no significant correlation between activity of either enzyme and that of monoamine oxidase. This shows that the low activity of platelet monoamine oxidase in headache is not related to a generalised platelet enzyme deficit. It was also shown that the low monoamine oxidase activity in the headache patients could not be attributed to smoking.

Full text

PDF
338

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Buchsbaum M. S., Coursey R. D., Murphy D. L. The biochemical high-risk paradigm: behavioral and familial correlates of low platelet monoamine oxidase activity. Science. 1976 Oct 15;194(4262):339–341. doi: 10.1126/science.968488. [DOI] [PubMed] [Google Scholar]
  2. Bussone G., Giovannini P., Boiardi A., Boeri R. A study of the activity of platelet monoamine oxidase in patients with migraine headaches or with 'cluster headaches'. Eur Neurol. 1977;15(3):157–162. doi: 10.1159/000114806. [DOI] [PubMed] [Google Scholar]
  3. Corash L. Platelet heterogeneity: relevance to the use of platelets to study psychiatric disorders. Schizophr Bull. 1980;6(2):254–258. doi: 10.1093/schbul/6.2.254. [DOI] [PubMed] [Google Scholar]
  4. Couch J. R., Hassanein R. S. Platelet aggregability in migraine. Neurology. 1977 Sep;27(9):843–848. doi: 10.1212/wnl.27.9.843. [DOI] [PubMed] [Google Scholar]
  5. Coursey R. D., Buchsbaum M. S., Murphy D. L. 2-year follow-up of subjects and their families defined as at risk for psychopathology on the basis of platelet MAO activities. 2-year follow-up of low platelet MAO. Neuropsychobiology. 1982;8(1):51–56. doi: 10.1159/000117877. [DOI] [PubMed] [Google Scholar]
  6. Deshmukh S. V., Meyer J. S., Mouche R. J. Platelet dysfunction in migraine: effect of self-medication with aspirin. Thromb Haemost. 1976 Nov 30;36(2):319–324. [PubMed] [Google Scholar]
  7. Ekbom E., Olivarius B. Chronic migrainous neuralgia--diagnostic and therapeutic aspects. Headache. 1971 Oct;11(3):97–101. doi: 10.1111/j.1526-4610.1971.hed1103097.x. [DOI] [PubMed] [Google Scholar]
  8. Foldes A., Meek J. L. Rat brain phenolsulfotransferase: partial purification and some properties. Biochim Biophys Acta. 1973 Dec 19;327(2):365–374. doi: 10.1016/0005-2744(73)90419-1. [DOI] [PubMed] [Google Scholar]
  9. Gattaz W. F., Beckmann H. Platelet MAO activity and personality characteristics. A study in schizophrenic patients and normal individuals. Acta Psychiatr Scand. 1981 May;63(5):479–485. doi: 10.1111/j.1600-0447.1981.tb00697.x. [DOI] [PubMed] [Google Scholar]
  10. Glover V., Peatfield R., Zammit-Pace R., Littlewood J., Gawel M., Rose F. C., Sandler M. Platelet monoamine oxidase activity and headache. J Neurol Neurosurg Psychiatry. 1981 Sep;44(9):786–790. doi: 10.1136/jnnp.44.9.786. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hanington E., Jones R. J., Amess J. A., Wachowicz B. Migraine: a platelet disorder. Lancet. 1981 Oct 3;2(8249):720–723. doi: 10.1016/s0140-6736(81)91049-7. [DOI] [PubMed] [Google Scholar]
  12. Kudrow L. Physical and personality characteristics in cluster headache. Headache. 1974 Jan;13(4):197–202. doi: 10.1111/j.1526-4610.1974.hed1304197.x. [DOI] [PubMed] [Google Scholar]
  13. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  14. Major L. F., Murphy D. L. Platelet and plasma amine oxidase activity in alcoholic individuals. Br J Psychiatry. 1978 Jun;132:548–554. doi: 10.1192/bjp.132.6.548. [DOI] [PubMed] [Google Scholar]
  15. Murphy D. L., Belmaker R. H., Buchsbaum M., Martin N. F., Ciaranello R., Wyatt R. J. Biogenic amine-related enzymes and personality variations in normals. Psychol Med. 1977 Feb;7(1):149–157. doi: 10.1017/s0033291700023229. [DOI] [PubMed] [Google Scholar]
  16. Murphy D. L., Donnelly C. H., Miller L., Wyatt R. J. Platelet monamine oxidase in chronic schizophrenia. Some enzyme characteristics relevant to reduced activity. Arch Gen Psychiatry. 1976 Nov;33(11):1377–1381. doi: 10.1001/archpsyc.1976.01770110105011. [DOI] [PubMed] [Google Scholar]
  17. Oreland L., Fowler C. J., Schalling D. Low platelet monoamine oxidase activity in cigarette smokers. Life Sci. 1981 Dec 14;29(24):2511–2518. doi: 10.1016/0024-3205(81)90706-2. [DOI] [PubMed] [Google Scholar]
  18. PENNINGTON R. J. Biochemistry of dystrophic muscle. Mitochondrial succinate-tetrazolium reductase and adenosine triphosphatase. Biochem J. 1961 Sep;80:649–654. doi: 10.1042/bj0800649. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Propping P., Rey E. R., Friedl W., Beckmann H. Platelet monoamine oxidase in healthy subjects: the "biochemical high-risk paradigm" revisited. Arch Psychiatr Nervenkr (1970) 1981;230(3):209–219. doi: 10.1007/BF00344446. [DOI] [PubMed] [Google Scholar]
  20. Rein G., Glover V., Sandler M. Sulphate conjugation of biologically active monoamines and their metabolites by human platelet phenolsulphotransferase. Clin Chim Acta. 1981 Apr 9;111(2-3):247–256. doi: 10.1016/0009-8981(81)90192-3. [DOI] [PubMed] [Google Scholar]
  21. Sandler M., Youdim M. B., Hanington E. A phenylethylamine oxidising defect in migraine. Nature. 1974 Jul 26;250(464):335–337. doi: 10.1038/250335a0. [DOI] [PubMed] [Google Scholar]
  22. Schooler C., Zahn T. P., Murphy D. L., Buchsbaum M. S. Psychological correlates of monoamine oxidase activity in normals. J Nerv Ment Dis. 1978 Mar;166(3):177–186. doi: 10.1097/00005053-197803000-00003. [DOI] [PubMed] [Google Scholar]
  23. Sicuteri F., Buffoni F., Anselmi B., Del Bianco P. L. An enzyme (MAO) defect on the platelets in migraine. Res Clin Stud Headache. 1970;3:245–251. [PubMed] [Google Scholar]
  24. Summers K. M., Brown G. K., Craig I. W., Littlewood J., Peatfield R., Glover V., Rose F. C., Sandler M. Platelet monoamine oxidase: specific activity and turnover number in headache. Clin Chim Acta. 1982 May 20;121(2):139–146. doi: 10.1016/0009-8981(82)90052-3. [DOI] [PubMed] [Google Scholar]
  25. VAHLQUIST B. Migraine in children. Int Arch Allergy Appl Immunol. 1955;7(4-6):348–355. doi: 10.1159/000228238. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES